Latest Views & News

Allied Minds still a sell after results - 3 times overvalued

By Janos Hipsley | Sunday 3 May 2015

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Allied Minds (ALM), as we have discussed previously, is an R&D-focused company with interests in “life sciences and high technology”. In its own words, “Allied Minds' core aim is to focus on early-stage disruptive technologies that it believes have significant upside potential and to realise that potential through supporting commercial development.” There are few instances of companies with almost zero revenue generation entering the FTSE-350, but this is one of them.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was